Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Objective: Determine tolerance of immediate oral intake (8 hours posterior to the beginning of treatment) against traditional management (early feeding at 48hr) in patients with mild acute pancreatitis of biliary origin.
Double blind, randomized clinical trial
The investigators included patients 15 - 85 years old, any sex. Diagnosis of mild acute pancreatitis according to the Ranson, APACHE II and BISAP.
Signed infromed consent to participate in the study. All participants had a hepatic and biliary ultrasound to determine the biliary etiology.
The investigators excluded patients with pancreatitis of nonbiliary etiology, pregnant, severe pancreatitis, cholangitis or choledocholithiasis demonstrated during the hospital stay or with other comorbidities.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Early oral feeding | Active Comparator | TIME OF FEEDING. 48 hours after pancreatitis general management is started ( liquid diet) |
|
| Immediate oral feeding | Experimental | TIME OF FEEDING: 8 hours of after pancreatitis general management is started (enteral formula) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| TIME OF FEEDING | Dietary Supplement | Liquid ( Re Feeding 8 h ) OR Enteral Feeding ( re feeding 48 h) |
|
| Measure | Description | Time Frame |
|---|---|---|
| Pancreatitis reactivation after oral Feeding | Resurgence of characteristically epigastric tansfictive pain, irradiated to the left, upper quadrant region after beginning the oral intake, systemic inflammatory response syndrome ( C reactive protein) or Significant leucocyte elevation | Measures at 24hours after the begining of the oral intake |
| Pancreatitis reactivation after oral Feeding | Resurgence of characteristically epigastric tansfictive pain, irradiated to the left, upper quadrant region after beginning the oral intake, systemic inflammatory response syndrome ( C reactive protein) or Significant leucocyte elevation | Measures at 48hours after the begining of the oral intake |
Not provided
Not provided
Inclusion Criteria:
Patients older than 15 years.
Exclusion Criteria:
Patients managed at another institution.
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Juan F Hernandez | Postgraduate office at UASLP | Study Chair |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010195 | Pancreatitis |
| D008224 | Lymphoma, Follicular |
| ID | Term |
|---|---|
| D010182 | Pancreatic Diseases |
| D004066 | Digestive System Diseases |
| D008228 | Lymphoma, Non-Hodgkin |
| D008223 | Lymphoma |
Not provided
Not provided
Not provided
Not provided
Not provided
blinding of the evaluator to the study group blinding of patient to study hypothesis
| D009370 |
| Neoplasms by Histologic Type |
| D009369 | Neoplasms |
| D008232 | Lymphoproliferative Disorders |
| D008206 | Lymphatic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
| D007160 | Immunoproliferative Disorders |
| D007154 | Immune System Diseases |